LAPSE:2023.5211
Published Article
LAPSE:2023.5211
Bladder Substitution: The Role of Tissue Engineering and Biomaterials
Martina Casarin, Alessandro Morlacco, Fabrizio Dal Moro
February 23, 2023
Abstract
Tissue engineering could play a major role in the setting of urinary diversion. Several conditions cause the functional or anatomic loss of urinary bladder, requiring reconstructive procedures on the urinary tract. Three main approaches are possible: (i) incontinent cutaneous diversion, such as ureterocutaneostomy, colonic or ileal conduit, (ii) continent pouch created using different segments of the gastrointestinal system and a cutaneous stoma, and (iii) orthotopic urinary diversion with an intestinal segment with spherical configuration and anastomosis to the urethra (neobladder, orthotopic bladder substitution). However, urinary diversions are associated with numerous complications, such as mucus production, electrolyte imbalances and increased malignant transformation potential. In this context, tissue engineering would have the fundamental role of creating a suitable material for urinary diversion, avoiding the use of bowel segments, and reducing complications. Materials used for the purpose of urinary substitution are biological in case of acellular tissue matrices and naturally derived materials, or artificial in case of synthetic polymers. However, only limited success has been achieved so far. The aim of this review is to present the ideal properties of a urinary tissue engineered scaffold and to examine the results achieved so far. The most promising studies have been highlighted in order to guide the choice of scaffolds and cells type for further evolutions.
Keywords
biomaterial, regenerative medicine, tissue engineering, urinary bladder, urinary diversions
Subject
Suggested Citation
Casarin M, Morlacco A, Dal Moro F. Bladder Substitution: The Role of Tissue Engineering and Biomaterials. (2023). LAPSE:2023.5211
Author Affiliations
Casarin M: Department of Surgery, Oncology and Gastroenterology, Giustiniani 2, 35128 Padua, Italy; L.i.f.e.L.a.b. Program, WP 14, Consorzio per la Ricerca Sanitaria (CORIS), Veneto Region, Via N. Giustiniani 2, 35128 Padua, Italy [ORCID]
Morlacco A: Department of Surgery, Oncology and Gastroenterology, Giustiniani 2, 35128 Padua, Italy; L.i.f.e.L.a.b. Program, WP 14, Consorzio per la Ricerca Sanitaria (CORIS), Veneto Region, Via N. Giustiniani 2, 35128 Padua, Italy
Dal Moro F: Department of Surgery, Oncology and Gastroenterology, Giustiniani 2, 35128 Padua, Italy; L.i.f.e.L.a.b. Program, WP 14, Consorzio per la Ricerca Sanitaria (CORIS), Veneto Region, Via N. Giustiniani 2, 35128 Padua, Italy
Journal Name
Processes
Volume
9
Issue
9
First Page
1643
Year
2021
Publication Date
2021-09-13
ISSN
2227-9717
Version Comments
Original Submission
Other Meta
PII: pr9091643, Publication Type: Review
Record Map
Published Article

LAPSE:2023.5211
This Record
External Link

https://doi.org/10.3390/pr9091643
Publisher Version
Download
Files
Feb 23, 2023
Main Article
License
CC BY 4.0
Meta
Record Statistics
Record Views
198
Version History
[v1] (Original Submission)
Feb 23, 2023
 
Verified by curator on
Feb 23, 2023
This Version Number
v1
Citations
Most Recent
This Version
URL Here
https://psecommunity.org/LAPSE:2023.5211
 
Record Owner
Auto Uploader for LAPSE
Links to Related Works
Directly Related to This Work
Publisher Version

[0.22 s]